Janux Therapeutics Q4 EPS $(0.51) Beats $(0.64) Estimate
Benzinga Newsdesk 8 months ago
EarningsEarnings BeatsNews
Janux Therapeutics (NASDAQ:JANX) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.64) by 20.19 percent. This is a 41.67 percent decrease over losses of $(0.36) per share
Janux Therapeutics (NASDAQ:JANX) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.64) by 20.19 percent. This is a 41.67 percent decrease over losses of $(0.36) per share from the same period last year.